American Diabetes Association
Browse

Novel T Cell reactivities to Hybrid Insulin Peptides in Islet Autoantibody-Positive At-Risk Subjects

Download (734.01 kB)
Version 2 2025-02-06, 21:32
Version 1 2025-01-17, 18:24
figure
posted on 2025-02-06, 21:32 authored by Anita C. Hohenstein, Joylynn Gallegos, Mylinh Dang, Jason Groegler, Hali Broncucia, Fatima Tensun, Kathleen Waugh, Fran Dong, Eddie A. James, Cate Speake, Andrea K. Steck, Marian J. Rewers, Peter A. Gottlieb, Kathryn Haskins, Thomas Delong, Rocky L. Baker

Type 1 Diabetes (T1D) is an autoimmune disease mediated by autoreactive T cells. Our studies indicate that CD4 T cells reactive to Hybrid Insulin Peptides (HIPs) play a critical role in T cell-mediated beta-cell destruction. We have shown that HIPs form in human islets between fragments of the C-peptide and cleavage products of secretory granule proteins. To identify T cell specificities contributing to T1D pathogenesis, we tested T cell reactivity from T1D patients or healthy control using an IFN-g ELISPOT assay against a library of 240 C-peptide HIPs. We observed elevated T cell responses to peptide pools containing HIPs that form at the amino acid residues G15, A18 and L26 of C-peptide. In a second cohort of healthy controls, at-risk individuals, and T1D patients, T cell reactivity to HIPs forming at these three residues was monitored. Results indicate that, prior to clinical onset of T1D, there were significantly elevated responses to multiple pools of HIPs, and the magnitude of T cell reactivity to HIPs forming at residue A18 of the C-peptide was increased. Overall, our study identifies new T cell specificities in at-risk subjects and indicates that T cell reactivity to HIPs can be observed before T1D onset.

Funding

This study was supported by the American Diabetes Association (ADA) ADA Junior Faculty Award 1-15-JF-04 (R.L.B.), ADA Pathway to stop Diabetes 1-15-ACE-14 (T.D.), National Institutes of Health (NIH) research grants R21AI133059 (R.L.B.), R01AI146202-01A1 (R.L.B.), R01DK081166 (K.H.), R01DK119529 (T.D), DRC NIDDK grant # P30-DK116073 and the Juvenile Diabetes Research Foundation grants 2-SRA-2016-226-S-B (T.D.).

History

Usage metrics

    Diabetes

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC